The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
955
Vinorelbine For Treatment of Advanced Non-Small-Cell Lung Cancer
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Vinorelbine For Treatment of Advanced Non-Small-Cell Lung Cancer
Vinorelbine (Navelbine - Burroughs Wellcome), a semisynthetic vinca alkaloid, has been approved by the US Food and Drug Administration for parenteral use in the treatment of advanced non-small-cell lung cancer (NSCLC). Various combinations of ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Vinorelbine For Treatment of Advanced Non-Small-Cell Lung Cancer
Article code: 955b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.